NPS Pharmaceuticals (NPSP) Mildly Higher after FDA Backing

October 16, 2012 4:21 PM EDT
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) resumes after FDA panel backing for Gattex. Shares are currently up about 1% to $10.29.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk, Trading Halts